Supreme Court: Promotion Suitability Must be Decided by Experts, Courts Cannot Create New Methods || SC: Market Integrity is Paramount; Rule Violators Cannot Escape Liability by Citing Investor Gains || SC: Plaintiff's Reply to Counterclaim in Commercial Suits Must Meet Written Statement Deadline || SC: Pre-2016 Debt Recovery Tribunal Recovery Certificates Cannot Support Insolvency Notices || SC: Children's Court Cannot Try Child as Adult Without Passing a Reasoned Order under JJ Act || SC: Contractual Clauses Denying Interest on Security Deposits Does Not Violate Public Policy || J&K&L HC: Unamended Pleading Loses Effect After Amendment; Party Cannot Benefit From Own Default || Allahabad HC: Wife's Maintenance Need Not be Fixed at 25% of Husband's Net Income || Kerala HC: Social Customs Alone Cannot Prove Bride Entrusted Gold to Husband or In-Laws || Karnataka HC: Century Club Qualifies as a Public Authority under the RTI Act Due to Land Grant

Drugs and Cosmetics (Amendment) Bill 2013 shelved - (22 Jun 2016)

Commercial

The Union Cabinet approved withdrawal of the Drugs and Cosmetics (Amendment) Bill 2013 from the Rajya Sabha.

Having been sent for examination, the Parliamentary Standing Committee recommended a plethora of changes to the Bill in light of rapid development in the pharmaceutical and cosmetic industries. The government will now rework the Bill comprehensively to encompass recent advances in research and development, and promoting a higher quality of products.

The Bill was tabled in Parliament on 29 August 2013, shortly after which it was referred to the Parliamentary Standing Committee on Health and Family Welfare.

Tags : DRUGS AND COSMETICS PHARMACEUTICAL CLINICAL TRIALS

Share :